Nishadil
Signup Signin
Delhi | 25°C (windy)
A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?

A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Load more..